SYSTM Wealth Solutions LLC Decreases Holdings in Zoetis Inc. (NYSE:ZTS)

SYSTM Wealth Solutions LLC trimmed its stake in shares of Zoetis Inc. (NYSE:ZTS) by 9.5% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 21,761 shares of the company’s stock after selling 2,285 shares during the period. SYSTM Wealth Solutions LLC’s holdings in Zoetis were worth $3,772,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in ZTS. Price T Rowe Associates Inc. MD lifted its holdings in Zoetis by 31.0% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 13,716,681 shares of the company’s stock valued at $2,707,262,000 after purchasing an additional 3,244,074 shares in the last quarter. Sarasin & Partners LLP raised its position in shares of Zoetis by 546.3% in the second quarter. Sarasin & Partners LLP now owns 2,253,590 shares of the company’s stock valued at $390,682,000 after buying an additional 1,904,899 shares during the last quarter. Swedbank AB acquired a new stake in shares of Zoetis in the first quarter valued at about $210,815,000. Public Employees Retirement Association of Colorado acquired a new stake in shares of Zoetis in the fourth quarter valued at about $242,757,000. Finally, CIBC Private Wealth Group LLC raised its position in shares of Zoetis by 122.6% in the fourth quarter. CIBC Private Wealth Group LLC now owns 1,448,665 shares of the company’s stock valued at $285,923,000 after buying an additional 797,884 shares during the last quarter. 92.80% of the stock is owned by hedge funds and other institutional investors.

Zoetis Trading Up 0.8 %

NYSE ZTS opened at $195.74 on Wednesday. The firm has a 50 day simple moving average of $183.65 and a 200-day simple moving average of $174.15. The company has a debt-to-equity ratio of 1.32, a quick ratio of 2.09 and a current ratio of 3.45. Zoetis Inc. has a one year low of $144.80 and a one year high of $201.92. The firm has a market cap of $88.68 billion, a price-to-earnings ratio of 37.71, a PEG ratio of 2.98 and a beta of 0.88.

Zoetis (NYSE:ZTS) last posted its quarterly earnings data on Tuesday, August 6th. The company reported $1.56 EPS for the quarter, beating the consensus estimate of $1.49 by $0.07. Zoetis had a net margin of 26.29% and a return on equity of 50.67%. The business had revenue of $2.36 billion during the quarter, compared to analyst estimates of $2.31 billion. During the same quarter last year, the firm posted $1.41 earnings per share. The business’s revenue for the quarter was up 8.3% compared to the same quarter last year. Equities research analysts anticipate that Zoetis Inc. will post 5.84 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently commented on the stock. Piper Sandler increased their target price on shares of Zoetis from $195.00 to $210.00 and gave the company an “overweight” rating in a research report on Wednesday, August 14th. Argus upgraded shares of Zoetis to a “strong-buy” rating in a research report on Friday, August 9th. BTIG Research increased their target price on shares of Zoetis from $220.00 to $225.00 and gave the company a “buy” rating in a research report on Monday, August 12th. Finally, Stifel Nicolaus restated a “buy” rating and set a $200.00 price objective on shares of Zoetis in a research report on Tuesday, August 27th. Nine analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, Zoetis has an average rating of “Buy” and a consensus price target of $217.11.

About Zoetis

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.